First-in-Class Drugs in Pipeline for Non-Small Cell Lung Cancer
b Newer drugs are in the pipeline for the treatment of Non-Small Cell Lung Cancer (NSCLC), which will provide targeted treatment and hopefully improve the prognosis of patients with lung cancer./b a...
View ArticleLung Cancer Screening With Low-Dose CT Could Be Cost Effective, Says...
Dartmouth scientists said that lung cancer screening in the National Lung Screening Trial (NLST) found a commonly accepted standard for cost effectiveness. This relatively new screening test uses...
View ArticleTrial Shows Treatment-resistant Advanced Non-small Cell Lung Cancer Responds...
In a phase I/II clinical trial, a promising result showed a new drug targeting common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC). The drug also targets a form...
View ArticleNew Genetic Anomalies Discovered in Lung Cancer
Patients whose tumors contained a large number of gene fusions had worse outcomes than patients with fewer gene fusions, according to researchers at the University of Michigan Comprehensive Cancer...
View ArticleSpread of Lung Cancer Revealed
The mystery behind the spreading of lung cancer was revealed by scientists. The researchers at the Cancer Research UK Manchester Institute discovered that the ties which lash cells together -...
View ArticleInstability of TIAM1 Protein Spreads Lung Cancer
The routine maintenance processes in a cell detect and remove faulty and worn out cell parts so they can be broken down and recycled. A protein called TIAM1 controls the links by which the cells are...
View ArticleCollaboration Will Help Improve Lung Cancer Surgery Outcomes
International collaboration between The Society of Thoracic Surgeons (STS) and the European Society of Thoracic Surgery (ESTS) will help improve the quality of patient care by linking outcomes data on...
View ArticleRisk of Lung Cancer Less in People Living at Higher Altitudes
Risk of lung cancer is much less in people living at higher altitudes, in both smokers and non-smokers, suggesting that oxygen may promote the incidence of lung cancer, reveals a new study....
View ArticleScientists Identify New Drug to Treat Lung Cancer
Researchers have identified a potential new drug target for treating lung cancer. In a new study by University of Kentucky Markey Cancer Center researchers have suggested that targeting a key enzyme...
View ArticleKRAS Pathway for Lung Cancer
Effective treatment of lung cancer has been challenging despite finding the KRAS gene as a target for treating lung cancer. The KRAS pathway is now explored to find what makes it cancerous. A new...
View ArticleAnti-Diabetic Drug may Decrease Lung Cancer Risk in Diabetic Nonsmokers
A new research suggests that an anti-diabetic drug, metformin, may lower lung cancer risk in diabetic nonsmokers. The research at the Kaiser Permanente Division of Research in Oakland, California,...
View ArticleLung Cancer Surpasses Breast Cancer in Rich Nations
Lung cancer surpasses breast cancer in being the leading cause of cancer death among women in developed nations, said researchers on Wednesday. The new analysis was led by researchers at the American...
View ArticleThough Difficult to Diagnose and Treat, Lung Cancer is Easy to Prevent
Lung cancer is the deadliest among all cancers with the highest annual mortality (1.6 million) as well as incidence (1.8 million) globally, and is responsible for nearly 1 in 5 cancer related deaths....
View ArticleNew Breathalyzer Shows Promise for Lung Cancer Screening
Researchers at the Chongqing University in China announce that they have been working on a sensor able to detect volatile organic compounds in a person's breath that point to the existence of lung...
View ArticleNeed for More Sensitive Lung Cancer Screening Criteria
A new analysis of lung cancer incidence and screening has revealed a decline in the proportion of patients with lung cancer meeting high-risk screening criteria, suggesting that an increasing number...
View ArticleNovartis Develops New Drug for Advanced Lung Cancer
Swiss drug manufacturers Novartis have developed a drug for advanced lung cancer. European health regulators have recommended approval of the drug, which is intended to treat patients with a specific...
View ArticleSkin Cancer Drug - Keytruda, Boosts Immune System to Fight Lung Cancer
Keytruda, the recently US approved drug shows early promise for some patients with advanced lung cancer though it is approved for advanced melanoma. The drug boosts the cancer-fighting potential and...
View ArticleUS and Cuban Cancer Research Centers Sign a Deal to Develop Lung Cancer Vaccine
The United States and Cuban cancer research centers have agreed to develop a lung cancer vaccine. Officials have signed a deal during a two-day visit by New York State Governor Andrew Cuomo and a...
View ArticleTerminal Lung Cancer Patient Will Walk Marathon to Raise Funds for Research
Angela Field, 39, a brave mother-of-two fighting terminal lung cancer, will walk the London Marathon on April 28 dressed as 'Superwoman' to inspire her children. Despite never smoking and having...
View ArticleUse of Statins Among Lung Cancer Patients Reduces Risk of Death from the Disease
Recently there has been an increasing interest in exploring new therapeutic uses of existing drugs, in part, because existing medications are relatively inexpensive and have known side effect...
View Article